Clinical Trial Update: Bevacizumab in the Radiation Treatment of Recurrent Malignant Glioma [NA]

View source ↗

Summary

This Clinical Trial Update reports that a trial of Bevacizumab in combination with radiation therapy for recurrent malignant glioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Cancer
• Brain Tumor
• Malignant Glioma

Drugs mentioned

• Bevacizumab (Avastin) (bevacizumab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Brain Cancer, Recurrent Malignant Gliomas | NA | Status: COMPLETED